Cervical Cancer Clinical Trials in Shanghai, Shanghai Municipality
14 recruitingShanghai, Shanghai Municipality, China
Showing 1–14 of 14 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC686 enrolled239 locationsNCT06459180
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Colorectal, CancerCervical CancerLung Cancer+4 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 2
A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer
Cervical CancerEndometrial Cancer
Sichuan Baili Pharmaceutical Co., Ltd.96 enrolled1 locationNCT07054567
Recruiting
Phase 3
A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer
Advanced Cervical Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd720 enrolled1 locationNCT07168200
Recruiting
Not Applicable
Modified Tumor-free Techniques Operation to Cervical Cancer
Cervical Cancer Stage IB2
Peking Union Medical College Hospital524 enrolled13 locationsNCT06836869
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects with Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.200 enrolled24 locationsNCT06799637
Recruiting
Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques.
Cervical CancerLymph Node MetastasisArtificial Intelligence
Obstetrics & Gynecology Hospital of Fudan University4,000 enrolled1 locationNCT06448897
Recruiting
Not Applicable
Toripalimab Combined With Definitive CCRT for LACC Patients
Cervical CancerImmunotherapyChemoradiotherapy
Ruijin Hospital150 enrolled1 locationNCT06256224
Recruiting
Phase 2
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer
Cervical Cancer
RemeGen Co., Ltd.116 enrolled12 locationsNCT06155396
Recruiting
Phase 1
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
Cervical CancerHead and Neck Squamous Cell CarcinomaAnal Cancer+3 more
HRYZ Biotech Co.32 enrolled1 locationNCT05952947
Recruiting
Phase 2
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Cervical CancerNeoadjuvant ImmunotherapyFertility-sparing Surgery
Xiaohua Wu30 enrolled1 locationNCT06209294
Recruiting
Phase 3
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
Cervical Cancer
Ruijin Hospital340 enrolled2 locationsNCT05277688
Recruiting
Not Applicable
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB3,IIA2)
Cervical Cancer
Obstetrics & Gynecology Hospital of Fudan University1,104 enrolled1 locationNCT04939831
Recruiting
Not Applicable
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB1,IB2,IIA1)
Cervical Cancer
Obstetrics & Gynecology Hospital of Fudan University780 enrolled1 locationNCT04929769